Therefore, combination of metformin, silymarin and renin-angiotensin system inhibitors or angiotensin receptor blockers may have additive kidney protective property beyond controlling the blood sugar of metformin, to prevent or slowing the progression of diabetic nephropathy. This evidence concerns the gene REN and diabetic kidney disease.